Table of Contents Introduction Hepatobiliary Disease Report Guidance Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Countries Contributing to Clinical Trials in Asia-Pacific Top Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials Clinical Trials by Phase in G7 Countries Clinical Trials in G7 Countries by Trial Status Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials Clinical Trials by Phase In Progress Trials by Phase Clinical Trials by Trial Status Unaccomplished Trials of Hepatobiliary Disease Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Prominent Drugs Clinical Trial Profiles Clinical Trial Overview of Top Companies Pfizer Inc. Clinical Trial Overview of Pfizer Inc. Clinical Trial Overview of Top Institutes / Government Hiroshima University Hospital Clinical Trial Overview of Hiroshima University Hospital Hokkaido University Hospital Clinical Trial Overview of Hokkaido University Hospital Osaka University Clinical Trial Overview of Osaka University The University of Tokyo Clinical Trial Overview of The University of Tokyo Chiba University Clinical Trial Overview of Chiba University Guangdong Science and Technology Department Clinical Trial Overview of Guangdong Science and Technology Department Haydarpasa Numune State Hospital Clinical Trial Overview of Haydarpasa Numune State Hospital Hokkaido University School of Medicine Clinical Trial Overview of Hokkaido University School of Medicine Japanese Endoscopist & IVRists group for Biliary Tract Cancer Clinical Trial Overview of Japanese Endoscopist & IVRists group for Biliary Tract Cancer Kyoto Prefectural University of Medicine Clinical Trial Overview of Kyoto Prefectural University of Medicine Five Key Clinical Profiles Appendix Abbreviations Definitions Research Methodology Secondary Research About GlobalData Contact Us Disclaimer Source List of Tables
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist & IVRists group for Biliary Tract Cancer, 2015* Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* List of Figures
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* GlobalData Methodology
|